A new research project could help improve diagnosis and treatment of bowel cancer - the third most common cancer in the world - by looking at how nanotechnology could be used to screen patients, with a simple blood test replacing the current tests.
The project, which has just been awarded £100,000 of funding by Cancer Research Wales, is led by Dean Harris, Honorary Professor in Swansea University’s College of Medicine, and a colorectal consultant at ABM Abertawe Bro Morgannwg University (ABMU) hHealth bBoard, working with Professor Peter Dunstan at Swansea University’s Centre for Nanohealth (CNH), and a dedicated PhD research student funded by the project.
- Wednesday 30 July 2014 14.17 GMT
- Monday 8 September 2014 14.18 GMT
- Rachel Smith